>
American billionaire reveals ambitious plans for high-tech floating city off the US coast
Thousands of flights delayed across the country after Delta outage triggers chaos ahead...
"They're Hiding Pedophiles": Only 23 Of 321 California School Districts Handed Over Te
Iran Dangles Deal As Bahrain Burns, Houthi Missiles Fly At Riyadh
Dubai Just Finished the World's First Permanent Air Taxi Route: Airport to the Marina in Under 1
Doroni Aerospace Raises More than $60m for H1?X Development
After 13 Years Battling Cancer, a 61-Year-Old Brazilian Man Achieved Complete Remission...
Extraterrestrial habitats may rise via Legos of laser-fused moon dust
Battery-only 19-seater puts China in the electric airliner race
Dream Chaser space plane gets landing approval for debut mission in 2027
SpaceX Just Caught Starship on Its FIRST Attempt!
Solid-State Cells Can Make The U.S. Competitive In Batteries Again: CEO
Jetson ONE personal eVTOL pod is about to go full sky patrol
America's INSANE BREAKTHROUGH Could Replace Septic Tanks Forever

This is huge. The FDA just granted orphan drug designation (ODD) to Insys Therapeutics for its pharmaceutical-grade, proprietary cannabidiol (CBD) product for treating cancer tumors in humans. Although glioma tumors affect less than 200,000 Americans, this FDA approval sets a precedent for natural remedies, and could lead to a revolutionary way to legally treat many forms of cancer with natural cures. In justifying preliminary approval of utilizing CBD to treat brain and spinal cancer tumors of this kind, Insys Therapeutics provided the FDA with the scientific rationale for CBD's benefits, including human experiences with the natural remedy, evidence discovered through in vitro studies, and preclinical animal testing.